Trial intelligence / Profile preview

Timing of Hormone Use in Septic Shock Patients

ChiCTR-OPC-16010118Phase 4Recruiting

Sponsor
The 2nd Affiliated Hospital of Harbin Medical University
Start
Dec 2016
Countries
1
01

Overview

Phase 4 trial of corticosteroids in septic shock (3 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoint: Shock reversal rate. Started Dec 2016; status: recruiting.

02

Drugs

corticosteroids
03

Conditions

septic shock

Beyond the preview

Go deeper on ChiCTR-OPC-16010118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPC-16010118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call